IFNB1 and myeloid sarcoma: Accordingly, in vitro stimulation with a TLR7 ligand (simulating viral RNA) promotes IgM and IgG production in PBMC cultures derived from IFN-β-treated MS patients as compared to the same individuals before therapy (21).